Singapore: Novartis has proceeded to acquire all remaining rights of GSK's Ofatumumab, a fully human monoclonal antibo...
Singapore: Bionomics, a biopharmaceutical company, has filed a patent application for BNC105 in combination with immune ...
Singapore: Tokyo-based Teijin Pharma, the core company of the Teijin Group's healthcare business, and Pulmagen Therapeu...
Singapore: Novartis has recieved USFDA approval for Promacta (eltrombopag) for the treatment of children six years and o...
Singapore: Agilent Technologies plans to collaborate with the University of Queensland Center for Clinical Research in B...
Singapore: Korea based CrystalGenomics has signed a sales and marketing agreement with Dong-A ST for the commercializati...
Tokyo: In collaboration with the Institute for Frontier Medical Sciences at Kyoto University, a team of CiRA researchers...
Singapore: AMRI has acquired all the outstanding shares of Spanish firm, Gadea Pharmaceutical Group, specializing in tec...
Singapore: Japan's Kowa Company and Chugai Pharmaceutical have entered into license agreement for liver cancer drug pere...
Singapore: SCIEX, a life science analytical technologies provider, and Metabolon, a global company focused on metabolomi...
Singapore: RaQualia Pharma and Interprotein entered into a collaborative research agreement. The partnership will focus...
Singapore: European Medicines Agency (EMA) has given a positive indication to Novartis' combination therapy of Tafinlar ...
Singapore: Dr Irwin Rose, an American biologist, who shared Nobel Prize in Chemistry in 2004 for the discovery of cell b...
Singapore: Novartis' phase III psoriasis study of secukinumab (AIN457) has showed positive outcome in clearing skin to E...
Singapore: China based diagnostic company, Shuwen Biotech, and pharmaceutical firm, Jiangsu Hengrui Medicine have partne...
Singapore: Bayer HealthCare and its development partner Janssen Pharmaceuticals have initiated the CALLISTO Clinical Res...
Singapore: ASLAN Pharmaceuticals has inked a memorandum of understanding with Singapore's National Cancer Center (NCCS) ...
Singapore: While the treatment pipeline for pancreatic cancer shows a high level of innovation, with 52 percent of produ...
